Generative AI has made producing business communications dramatically faster, but speed does not necessarily make a presentation, executive update or email more effective. The Presentation Company is putting that distinction at the center of a free August 26 webinar, arguing that professionals need to define the audience, message and desired outcome before asking AI to…
EVERSANA is expanding its AI-powered commercialization platform beyond marketing, adding capabilities for medical affairs, market research, field sales and other functions across the pharmaceutical commercialization process. The move reflects a broader shift in life sciences AI adoption: companies are moving from isolated generative AI experiments toward connected workflows that can automate repetitive work while preserving…
The agentic AI market is moving from chatbot experimentation toward software that can plan tasks, use enterprise tools and execute multi-step workflows with increasing autonomy. A new MarketsandMarkets forecast estimates the global market will grow from $19.33 billion in 2026 to $205.88 billion by 2033, representing a 40.2% compound annual growth rate. The projection highlights…
Artificial intelligence is changing jobs faster than many HR organizations can redefine what good performance looks like. New research from talent-management company Talogy suggests that while most organizations already use talent assessments, HR leaders are struggling to measure the combination of AI fluency, critical thinking, adaptability and data literacy that increasingly determines whether employees can…
AI drug discovery is moving from experimental research projects into the pipelines of major pharmaceutical companies. Chai Discovery has partnered with Bristol Myers Squibb (BMS) to use AI models for therapeutic antibody discovery, giving the drugmaker access to Chai’s molecular prediction and design technology as BMS builds what it describes as a continuously learning, AI-powered…
